GO
Loading...

There has been a 'tectonic shift' in biotech: Sanofi CEO

Wednesday, 22 Jan 2014 | 2:05 AM ET

Chris Viehbacher, CEO of Sanofi, says 2013 was a big year for biotech IPOs as companies were coming to market to access cash for the first time after many years.